SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 4/30/20 Idexx Laboratories Inc/DE 10-Q 3/31/20 101:9.4M |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 1.23M 2: EX-10.1 Material Contract HTML 31K 3: EX-10.2 Material Contract HTML 35K 4: EX-31.1 Certification -- §302 - SOA'02 HTML 35K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 35K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 30K 7: EX-32.2 Certification -- §906 - SOA'02 HTML 30K 21: R1 Cover Page HTML 80K 79: R2 Condensed Consolidated Balance Sheets HTML 142K 90: R3 Condensed Consolidated Balance Sheets HTML 41K (Parenthetical) 56: R4 Condensed Consolidated Statements of Income HTML 97K 20: R5 Condensed Consolidated Statements of Comprehensive HTML 69K Income 78: R6 Condensed Consolidated Statements of Comprehensive HTML 39K Income (Parenthetical) 89: R7 Condensed Consolidated Statements of Stockholders' HTML 62K Equity (Deficit) 51: R8 Condensed Consolidated Statements of Stockholders' HTML 29K Equity (Deficit) (Parenthetical) 22: R9 Condensed Consolidated Statements of Cash Flows HTML 113K 15: R10 Basis of Presentation and Principles of HTML 38K Consolidation 48: R11 Accounting Policies HTML 34K 80: R12 Revenue Recognition HTML 118K 67: R13 Acquisitions HTML 31K 16: R14 Share-Based Compensation HTML 44K 49: R15 Credit Losses HTML 37K 81: R16 Inventories HTML 38K 68: R17 Leases HTML 51K 17: R18 Other Current and Long-Term Assets HTML 55K 47: R19 Accrued Liabilities HTML 48K 100: R20 Debt HTML 93K 64: R21 Repurchases Of Common Stock HTML 49K 35: R22 Income Taxes HTML 31K 42: R23 Accumulated Other Comprehensive Income HTML 105K 101: R24 Earnings Per Share HTML 47K 65: R25 Commitments, Contingencies and Guarantees HTML 33K 36: R26 Segment Reporting HTML 145K 43: R27 Fair Value Measurements HTML 112K 99: R28 Hedging Instruments HTML 102K 66: R29 Subsequent Events (Notes) HTML 30K 71: R30 Accounting Policies (Policies) HTML 76K 84: R31 Revenue Recognition (Tables) HTML 60K 46: R32 Share-Based Compensation (Tables) HTML 40K 14: R33 Inventories (Tables) HTML 39K 70: R34 Leases (Tables) HTML 47K 83: R35 Other Current and Long-Term Assets (Tables) HTML 57K 45: R36 Accrued Liabilities (Tables) HTML 49K 13: R37 Debt (Tables) HTML 85K 69: R38 Repurchases of Common Stock (Tables) HTML 49K 85: R39 Accumulated Other Comprehensive Income (Tables) HTML 106K 61: R40 Earnings Per Share (Tables) HTML 47K 95: R41 Segment Reporting (Tables) HTML 143K 41: R42 Fair Value Measurements (Tables) HTML 101K 32: R43 Hedging Instruments (Tables) HTML 85K 60: R44 Accounting Policies (Details) HTML 44K 94: R45 Revenue Recognition (General Narrative) (Details) HTML 32K 40: R46 Revenue Recognition (Lease Revenue) (Details) HTML 29K 31: R47 Revenue Recognition (Extended Warranties and HTML 43K Post-Contract Support) (Details) 59: R48 Revenue Recognition (Remaining Performance HTML 73K Obligation) (Details) 96: R49 Revenue Recognition (SaaS Subscriptions) (Details) HTML 30K 87: R50 Revenue Recognition (Up-Front Customer Loyalty HTML 33K Programs) (Details) 72: R51 Revenue Recognition (Volume Commitment Programs) HTML 38K (Details) 26: R52 Revenue Recognition (Instrument Rebate Programs) HTML 33K (Details) 57: R53 Revenue Recognition (Reagent Rental Programs) HTML 40K (Details) 88: R54 Revenue Recognition (Disaggregation of Revenue by HTML 54K Major Product and Service Categories) (Details) 73: R55 Revenue Recognition (Disaggregation of Revenue by HTML 40K Principal Geographic Area, Based on Customers' Domiciles) (Details) 27: R56 Revenue Recognition (Costs to Obtain a Contract) HTML 38K (Details) 58: R57 Acquisitions Acquisitions (Details) HTML 44K 86: R58 Share-Based Compensation (Narrative) (Details) HTML 38K 74: R59 Share-Based Compensation (Assumptions Used) HTML 39K (Details) 28: R60 Credit Losses (Details) HTML 41K 38: R61 Inventories (Details) HTML 38K 97: R62 Leases (Maturities of Operating Lease Liabilities) HTML 56K (Details) 62: R63 Leases (Narrative) (Details) HTML 37K 29: R64 Leases (Supplemental Cash Flow Information) HTML 31K (Details) 39: R65 Other Current and Long-Term Assets (Schedule Of HTML 45K Other Current Assets) (Details) 98: R66 Other Current and Long-Term Assets (Schedule Of HTML 47K Other Long-term Assets) (Details) 63: R67 Accrued Liabilities (Schedule Of Accrued HTML 43K Liabilities) (Details) 30: R68 Accrued Liabilities (Schedule Of Other Long-term HTML 35K Liabilities) (Details) 37: R69 Debt Debt (Schedule of Current Senior Notes HTML 64K Outstanding) (Details) 53: R70 Debt Debt (Narrative) (Details) HTML 57K 24: R71 Repurchases of Common Stock (Details) HTML 47K 76: R72 Income Taxes (Details) HTML 30K 92: R73 Accumulated Other Comprehensive Income (Schedule HTML 57K Of AOCI) (Details) 52: R74 Accumulated Other Comprehensive Income (Schedule HTML 42K of Reclassifications out of AOCI) (Details) 23: R75 Earnings Per Share (Schedule Of Reconciliation Of HTML 38K Shares Outstanding For Basic And Diluted Earnings Per Share) (Details) 75: R76 Earnings Per Share (Schedule Of Number Of HTML 34K Anti-Dilutive Stock Options) (Details) 91: R77 Segment Reporting - Allocated Costs (Details) HTML 73K 55: R78 Segment Reporting - Summary of Segment Performance HTML 68K (Details) 18: R79 Fair Value Measurements (Narrative) (Details) HTML 33K 54: R80 Fair Value Measurements (Schedule of Assets and HTML 73K Liabilities) (Details) 25: R81 Hedging Instruments (Narrative) (Details) HTML 61K 77: R82 Hedging Instruments (Derivatives Designated In HTML 35K Cash Flow Hedging Relationships) (Details) 93: R83 Hedging Instruments (Schedule Of Fair Values And HTML 66K Balance Sheet Classifications Of Derivatives Designated As Hedging Instruments) (Details) 50: R84 Subsequent Events (Details) HTML 39K 34: XML IDEA XML File -- Filing Summary XML 187K 19: XML XBRL Instance -- idxx2020q110-q_htm XML 2.35M 33: EXCEL IDEA Workbook of Financial Reports XLSX 98K 9: EX-101.CAL XBRL Calculations -- idxx-20200331_cal XML 269K 10: EX-101.DEF XBRL Definitions -- idxx-20200331_def XML 631K 11: EX-101.LAB XBRL Labels -- idxx-20200331_lab XML 1.57M 12: EX-101.PRE XBRL Presentations -- idxx-20200331_pre XML 1.00M 8: EX-101.SCH XBRL Schema -- idxx-20200331 XSD 172K 44: JSON XBRL Instance as JSON Data -- MetaLinks 370± 540K 82: ZIP XBRL Zipped Folder -- 0000874716-20-000018-xbrl Zip 306K
Download this zipped .zip folder | |
Files: | a102ayerssenioradvisor.htm idxx-20180331x10qg001a06.jpg idxx-20180331x10qg002a05.jpg idxx-20180331x10qg003a06.jpg idxx-20180331x10qg004a07.jpg idxx-20200331.xsd idxx-20200331_cal.xml idxx-20200331_def.xml idxx-20200331_lab.xml idxx-20200331_pre.xml idxx2020q110-q.htm idxx2020q110-qexhibit311.htm idxx2020q110-qexhibit312.htm idxx2020q110-qexhibit321.htm idxx2020q110-qexhibit322.htm ortholetterwaiver-conf.htm |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/22/24 IDEXX Laboratories, Inc. 10-K 12/31/23 140:15M 2/16/23 IDEXX Laboratories, Inc. 10-K 12/31/22 136:15M 2/16/22 IDEXX Laboratories, Inc. 10-K 12/31/21 151:18M 2/12/21 IDEXX Laboratories, Inc. 10-K 12/31/20 131:15M |